Edition:
United States

Bellicum Pharmaceuticals Inc (BLCM.OQ)

BLCM.OQ on NASDAQ Stock Exchange Global Market

4.29USD
16 Nov 2018
Change (% chg)

$-0.20 (-4.45%)
Prev Close
$4.49
Open
$4.44
Day's High
$4.60
Day's Low
$4.25
Volume
88,272
Avg. Vol
99,923
52-wk High
$10.37
52-wk Low
$3.92

Chart for

About

Bellicum Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing cellular immunotherapies for various forms of cancer, including hematological cancers and solid tumors, as well as orphan inherited blood disorders. The Company uses its chemical induction of... (more)

Overall

Beta: 1.02
Market Cap(Mil.): $182.55
Shares Outstanding(Mil.): 43.36
Dividend: --
Yield (%): --

Financials

  BLCM.OQ Industry Sector
P/E (TTM): -- 79.62 29.34
EPS (TTM): -2.47 -- --
ROI: -71.80 -0.41 13.58
ROE: -94.83 -3.13 15.11

Earnings vs. Estimates